G1 Therapeutics
Stock Forecast, Prediction & Price Target
G1 Therapeutics Financial Estimates
G1 Therapeutics Revenue Estimates
G1 Therapeutics EBITDA Estimates
G1 Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $31.47M N/A | $51.30M 62.98% | $82.51M 60.83% | Avg: $92.33M Low: $67.02M High: $112.17M avg. 11.90% | Avg: $327.33M Low: $257.04M High: $384.81M avg. 254.49% | Avg: $131.42M Low: $103.20M High: $154.50M avg. -59.84% | Avg: $159.92M Low: $125.58M High: $188.00M avg. 21.68% |
Net Income
% change YoY
| $-148.35M N/A | $-147.55M 0.53% | $-47.96M 67.49% | Avg: $-12.75M Low: $-33.62M High: $2.06M avg. 73.41% | Avg: $185.23M Low: $-25.86M High: $1.01B avg. 1552.69% | Avg: $12.15M Low: $8.76M High: $14.93M avg. -93.43% | Avg: $25.34M Low: $18.27M High: $31.13M avg. 108.51% |
EBITDA
% change YoY
| $-142.76M N/A | $-134.89M 5.50% | $-39.01M 71.07% | Avg: $-45.66M Low: $-55.47M High: $-33.14M avg. -17.05% | Avg: $-161.88M Low: $-190.31M High: $-127.12M avg. -254.49% | Avg: $-65.00M Low: $-76.41M High: $-51.04M avg. 59.84% | Avg: $-79.09M Low: $-92.98M High: $-62.10M avg. -21.68% |
EPS
% change YoY
| -$3.54 N/A | -$3.38 4.51% | -$0.93 72.48% | Avg: -$0.17 Low: -$0.65 High: $0.04 avg. 81.37% | Avg: $3.88 Low: -$0.5 High: $19.66 avg. 2338.15% | Avg: $0.24 Low: $0.17 High: $0.29 avg. -93.93% | Avg: $0.49 Low: $0.35 High: $0.6 avg. 108.51% |
Operating Expenses
% change YoY
| $171.91M N/A | $183.73M 6.87% | $114.84M -37.49% | Avg: $154.61M Low: $112.21M High: $187.83M avg. 34.62% | Avg: $548.09M Low: $430.39M High: $644.33M avg. 254.49% | Avg: $220.06M Low: $172.80M High: $258.71M avg. -59.84% | Avg: $267.78M Low: $210.27M High: $314.80M avg. 21.68% |
FAQ
What is G1 Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 410.29% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -33.62M, average is -12.75M and high is 2.06M.
What is G1 Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 57.05% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $67.02M, average is $92.33M and high is $112.17M.
What is G1 Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 608.52% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.65, average is -$0.17 and high is $0.04.
What is the best performing analyst?
In the last twelve months analysts have been covering G1 Therapeutics stock. The most successful analyst is Gil Blum.